Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Halozyme Therapeutics
(HTI) Q2 2026
Earnings
HTI
May 12
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.24
0.57
1.39
2.2
Details
Expected EPS
1.528
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A
Description
Halozyme Therapeutics (HTI) will report earnings of for Q2 2026 on May 12, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login